Cargando…
Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibio...
Autores principales: | Hussain, Khandakar, Ullah, Saad, Tahir, Hassan, Alkilani, Waseem Zaid, Naeem, Muhammad, Vinod, Nagadarshini Ramagiri, Massoud, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027907/ https://www.ncbi.nlm.nih.gov/pubmed/27689100 http://dx.doi.org/10.1177/2324709616665408 |
Ejemplares similares
-
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China
por: Wang, Shanshan, et al.
Publicado: (2016) -
Quinupristin/Dalfopristin-induced Sweet’s Syndrome
por: Choi, Hye Sook, et al.
Publicado: (2003) -
The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism
por: Shaw, Timothy D., et al.
Publicado: (2018) -
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
por: El-Azizi, Mohamed, et al.
Publicado: (2005) -
Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2014)